D-Pharm Receives Agreement Letter On Special Protocol Assessment For DP-b99 Study – A Pivotal Phase III Trial In Acute …

D-Pharm Receives Agreement Letter On Special Protocol Assessment For DP-b99 Study – A Pivotal Phase III Trial In Acute …
D-Pharm Ltd (DPRM: TASE) announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) procedure for a pivotal phase 3 trial (MACSI) of its neuroprotective agent DP-b99 in acute ischemic stroke patients. The SPA agreement letter indicates that “the design and planned analysis of the study adequately address the objectives …

Read more on Medical News Today

Biotechnology, Special Processes

Product Description
Volume 10 on Special Processes completes the Second Edition of the Biotech series providing an overview on innovative and special fields of biotechnology. In the other volumes of the series many larger areas of biotechnology are treated with respect to principal aspects, while Volume 10 covers more specialized topics.
Areas which are anticipated to have a highly promising future are nanobiotechnology, bioelectrochemical fuel cells, bacteriorhodopsin and other substances used as information systems.
Further fields – even though small – are of current importance such as marine biotechnology, biotechnology in phytopathology, biotechnology with extremophiles, and biotechnology with protozoa.
Volume 10 enables the reader to access these and further special fields of biotechnology. The proven calibre of extensive references provides a good basis to acquire further insight into the fields.

Biotechnology, Special Processes

Special Report: Fast machines, genes and the future of medicine

Special Report: Fast machines, genes and the future of medicine
Francis Collins, who helped map the human genome, did not get around to having his own genes examined until last summer. And he was surprised by what he learned.

Read more on Reuters via Yahoo! News